Chinese Cos. Can't Shake Vitamin C Antitrust MDL

Law360, New York (September 7, 2011, 3:00 PM EDT) -- A New York federal judge on Tuesday denied a bid by a group of Chinese companies to exit multidistrict antitrust litigation over vitamin C, rejecting their claim that they were entitled to summary judgment because the Chinese government compelled them to fix prices.

In a 72-page memorandum decision and order dated Sept. 1 and docketed Tuesday, U.S. District Judge Brian Cogan nixed a summary judgment motion filed in 2009 by defendants HeBei Welcome Pharmaceutical Co. Ltd., Aland (Jiangsu) Nutraceutical Co. Ltd., Northeast Pharmaceutical Group Co. Ltd....
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.